Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
8.04
-3.62 (-31.05%)
At close: Mar 18, 2026, 4:00 PM EDT
8.01
-0.03 (-0.37%)
After-hours: Mar 18, 2026, 7:59 PM EDT
Cingulate Employees
Cingulate had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,726,916
Market Cap
93.49M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | -1 | -6.25% |
| Dec 31, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2021 | 13 | 1 | 8.33% |
| Jun 30, 2021 | 13 | - | - |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 171 |
| PolyPid | 73 |
| PMV Pharmaceuticals | 54 |
| BeyondSpring | 40 |
| NeurAxis | 21 |
| iBio, Inc. | 20 |
| Annovis Bio | 15 |
| MediciNova | 13 |
CING News
- 2 days ago - Why did Cingulate stock skyrocket today? - Invezz
- 4 months ago - Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25 - Newsfile Corp
- 5 months ago - Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting - GlobeNewsWire
- 6 months ago - Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment - GlobeNewsWire
- 7 months ago - Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25 - Newsfile Corp
- 7 months ago - Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights - GlobeNewsWire
- 7 months ago - Cingulate Provides Management Team Update - GlobeNewsWire
- 8 months ago - Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301 - GlobeNewsWire